262 related articles for article (PubMed ID: 15771301)
1. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective.
Usaj S; Tarabar D; Cuk V; Cerovic S; Brajukovic G; Panisic M; Klem I; Eric Z
Acta Chir Iugosl; 2004; 51(2):109-16. PubMed ID: 15771301
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic problems and advances in inflammatory bowel disease.
Odze R
Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
Lynch HT; Brand RE; Locker GY
Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
[TBL] [Abstract][Full Text] [Related]
4. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
5. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
[TBL] [Abstract][Full Text] [Related]
6. Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases.
Ten Hove JR; Mooiweer E; Dekker E; van der Meulen-de Jong AE; Offerhaus GJ; Ponsioen CY; Siersema PD; Oldenburg B
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):222-228.e2. PubMed ID: 27613257
[TBL] [Abstract][Full Text] [Related]
7. Endoscopy/surveillance in inflammatory bowel disease.
Ahmadi AA; Polyak S
Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
[TBL] [Abstract][Full Text] [Related]
8. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
[TBL] [Abstract][Full Text] [Related]
9. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
10. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
Shergill AK; Farraye FA
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Cancer Screening in Inflammatory Bowel Disease.
Sengupta N; Yee E; Feuerstein JD
Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
Itzkowitz SH; Harpaz N
Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
15. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
[TBL] [Abstract][Full Text] [Related]
16. Pathology of dysplasia and cancer in inflammatory bowel disease.
Mescoli C; Frego M; Rugge M
Ann Ital Chir; 2011; 82(1):11-8. PubMed ID: 21657150
[TBL] [Abstract][Full Text] [Related]
17. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients.
Torres C; Antonioli D; Odze RD
Am J Surg Pathol; 1998 Mar; 22(3):275-84. PubMed ID: 9500769
[TBL] [Abstract][Full Text] [Related]
18. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the distinct histomorphologic features of inflammatory bowel disease-associated neoplastic precursor lesions in the SCENIC and post-DALM Era.
Gui X; Iacucci M; Ghosh S; Ferraz JGP; Lee S
Hum Pathol; 2020 Jun; 100():24-37. PubMed ID: 32387105
[TBL] [Abstract][Full Text] [Related]
20. Cancer prevention in patients with inflammatory bowel disease.
Itzkowitz SH
Gastroenterol Clin North Am; 2002 Dec; 31(4):1133-44. PubMed ID: 12489282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
